Assessment of the feasibility of exon 45–55 multiexon skipping for duchenne muscular dystrophy

BACKGROUND: The specific skipping of an exon, induced by antisense oligonucleotides (AON) during splicing, has shown to be a promising therapeutic approach for Duchenne muscular dystrophy (DMD) patients. As different mutations require skipping of different exons, this approach is mutation dependent....

Descripción completa

Detalles Bibliográficos
Autores principales: van Vliet, Laura, de Winter, Christa L, van Deutekom, Judith CT, van Ommen, Gert-Jan B, Aartsma-Rus, Annemieke
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2611974/
https://www.ncbi.nlm.nih.gov/pubmed/19046429
http://dx.doi.org/10.1186/1471-2350-9-105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2611974/
https://www.ncbi.nlm.nih.gov/pubmed/19046429
http://dx.doi.org/10.1186/1471-2350-9-105

Ejemplares similares